Atea Pharmaceuticals (AVIR) Insider Trading & Ownership $3.40 +0.04 (+1.19%) Closing price 04:00 PM EasternExtended Trading$3.40 0.00 (0.00%) As of 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atea Pharmaceuticals (NASDAQ:AVIR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.17M Get AVIR Insider Trade Alerts Want to know when executives and insiders are buying or selling Atea Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVIR Insider Buying and Selling by Quarter Atea Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/10/2024Franklin M BergerDirectorSell359,606$2.85$1,024,877.10 9/19/2024Jean-Pierre SommadossiCEOSell1,841$4.00$7,364.00 9/17/2024Jean-Pierre SommadossiCEOSell33,941$4.05$137,461.05 (Data available from 1/1/2013 forward) AVIR Insider Trading Activity - Frequently Asked Questions Who is on Atea Pharmaceuticals' Insider Roster? The list of insiders at Atea Pharmaceuticals includes Andrea Corcoran, Bruce Polsky, Franklin M Berger, Jean-Pierre Sommadossi, and Wayne Foster. Learn more on insiders at AVIR. What percentage of Atea Pharmaceuticals stock is owned by insiders? 18.10% of Atea Pharmaceuticals stock is owned by insiders. Learn more on AVIR's insider holdings. Which Atea Pharmaceuticals insiders have been selling company stock? The following insiders have sold AVIR shares in the last 24 months: Andrea Corcoran ($60,837.12), Bruce Polsky ($61,228.56), Franklin M Berger ($1,024,877.10), Jean-Pierre Sommadossi ($367,952.55), and Wayne Foster ($47,911.68). How much insider selling is happening at Atea Pharmaceuticals? Insiders have sold a total of 499,168 Atea Pharmaceuticals shares in the last 24 months for a total of $1,562,807.01 sold. Atea Pharmaceuticals Key ExecutivesDr. Jean-Pierre Sommadossi Ph.D. (Age 68)Founder, Chairman, CEO & President Compensation: $1.04MMs. Andrea J. Corcoran J.D. (Age 62)CFO, Executive VP of Legal & Secretary Compensation: $712.48kMr. Wayne Foster CPA (Age 55)Executive VP of Finance & Chief Accounting Officer Compensation: $580.46kDr. Janet M. J. Hammond M.D. (Age 64)Ph.D., Chief Development Officer Compensation: $789.47kDr. Maria Arantxa Horga M.D. (Age 56)Chief Medical Officer Compensation: $679.58kMs. Jonae R. BarnesSenior Vice President of Investor Relations & Corporate CommunicationsMr. Ariyapadi N. KrishnarajVice President of MarketingMr. Adel Moussa Ph.D.Executive Vice President of ChemistryMr. Xiao-Jian Zhou Ph.D.Executive Vice President of Early Stage DevelopmentMr. John F. Vavricka (Age 61)Chief Commercial Officer Compensation: $581.11k More Insider Trading Tools from MarketBeat Related Companies Mineralys Therapeutics Insider Trades Nuvation Bio Insider Trades Spyre Therapeutics Insider Trades Cronos Group Insider Trades Oric Pharmaceuticals Insider Trades atai Life Sciences Insider Trades Praxis Precision Medicines Insider Trades Upstream Bio Insider Trades Urogen Pharma Insider Trades uniQure Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling ThereCostco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks This page (NASDAQ:AVIR) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVIR Stock Alerts